| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
166,400
5.03% |
5.03%
|
₹1.41 |
|
QIB
|
Over 1.00x
|
1,332,800
40.28% |
40.28%
|
₹11.33 |
|
NII / HNI
|
Over 1.00x
|
542,400
16.39% |
16.39%
|
₹4.61 |
|
Retail
|
Over 1.00x
|
1,267,200
38.3% |
38.3%
|
₹10.77 |
| Total | 1.00x | 3,308,800 |
100% | ₹28.12 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 1,332,800 | ₹11.33 |
40.28%
|
| Market Maker | 166,400 | ₹1.41 |
5.03%
|
| NII | 542,400 | ₹4.61 |
16.39%
|
| Retail | 1,267,200 | ₹10.77 |
38.30%
|
| Total | 3,308,800 | ₹28.12 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 542,400 | 1,267,200 | 1,809,600 |
| Allotment price (₹) | 85 | 85 | 85 | 85 | 85 | 85 | 85 | 85 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹10.77 | ₹10.77 |
| Times subscribed | 1 | — | — | — | — | 1 | 1 | 1 |
| Shares allotted | — | — | — | — | — | 542,400 | 1,267,200 | 1,809,600 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 3,200 | ₹272,000 |
| Retail (Max — 13 Lots) | 13 | 20,800 | ₹1,768,000 |
| S-HNI (Min — 14 Lots) | 14 | 22,400 | ₹1,904,000 |
| B-HNI (Min — 68 Lots) | 68 | 108,800 | ₹9,248,000 |
Invicta Diagnostic Ltd is proposing an IPO on NSE SME under the SME category. Total issue: 33,08,800 shares (aggregating up to ₹28.12 Cr).
Opens 01 Dec 2025, closes 03 Dec 2025. Listing: 08 Dec 2025. Apply via ASBA or UPI.
| Particulars | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 17.08 | 30.18 | 15.90 |
| EBITDA | 6.77 | 9.20 | 7.09 |
| Profit After Tax (PAT) | 4.08 | 4.93 | 3.81 |
| Net Worth | 23.68 | 13.60 | 8.67 |
| Total Assets | 34.90 | 21.22 | 15.89 |
| Reserves & Surplus | 14.42 | 5.18 | 8.54 |
| Borrowings | 3.72 | 3.54 | 3.81 |
| EBITDA Margin (%) | 30.57% | — | — |
| PAT Margin (%) | 16.38% | — | — |
Invicta Diagnostic Ltd IPO is subscribed 1.00 times by Dec 03, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Invicta Diagnostic Ltd IPO retail category is subscribed 1.00 times as of 03 Dec 2025. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 01 Dec 2025 and closes 03 Dec 2025. Min investment: ₹136,000 (1 lot = 1,600 shares). UPI mandate: 2025-12-03.
The Invicta Diagnostic Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 09 Dec 2025. Refunds: on 10 Dec 2025.
The Invicta Diagnostic Ltd IPO listing date is 08 Dec 2025, Monday. Listed on: NSE SME. Issue price: ₹85. Estimated listing: ₹85. GMP: NIL.
The Invicta Diagnostic Ltd IPO closes on 03 Dec 2025, Wednesday. UPI mandate: 2025-12-03. Allotment: 09 Dec 2025. Listing: 08 Dec 2025.